Adaptive and Constitutive Activations of Malic Enzymes Confer Liver Cancer Multilayered Protection Against Reactive Oxygen Species

Derek Lee, Misty Shuo Zhang, Felice Ho‐Ching Tsang, Macus Hao‐Ran Bao, Iris Ming‐Jing Xu, Robin Kit‐Ho Lai, David Kung‐Chun Chiu, Aki Pui‐Wah Tse, Cheuk‐Ting Law, Cerise Yuen‐Ki Chan, Vincent Wai‐Hin Yuen, Noreen Nog‐Qin Chui, Irene Oi‐Lin Ng, Chun‐Ming Wong, Carmen Chak‐Lui Wong – 21 February 2021

Patient Determinants for Histologic Diagnosis of NAFLD in the Real World: A TARGET‐NASH Study

A. Sidney Barritt, Stephanie Watkins, Norman Gitlin, Samuel Klein, Anna S. Lok, Rohit Loomba, Cheryl Schoen, K. Rajender Reddy, Huy Ngoc Trinh, Andrea R. Mospan, Miriam B. Vos, L. Michael Weiss, Kenneth Cusi, Brent A. Neuschwander‐Tetri, Arun J. Sanyal – 20 February 2021 – Much of the current data on nonalcoholic fatty liver disease (NAFLD) are derived from biopsy‐based studies that may introduce ascertainment and selection bias. Selection of patients for liver biopsy has implications for clinical practice and the reported epidemiology of NAFLD.

Characterization of Acute HCV Infection and Transmission Networks in People Who Currently Inject Drugs in Catalonia: Usefulness of Dried Blood Spots

Adrián Antuori, Vincent Montoya, David Piñeyro, Lauro Sumoy, Jeffrey Joy, Mel Krajden, Sara González‐Gómez, Cinta Folch, Jordi Casabona, Lurdes Matas, Joan Colom, Verónica Saludes, Elisa Martró, HepCdetect II Study Group – 19 February 2021

Microbiota‐Driven Activation of Intrahepatic B Cells Aggravates NASH Through Innate and Adaptive Signaling

Fanta Barrow, Saad Khan, Gavin Fredrickson, Haiguang Wang, Katrina Dietsche, Preethy Parthiban, Sacha Robert, Thomas Kaiser, Shawn Winer, Adam Herman, Oyedele Adeyi, Marialena Mouzaki, Alexander Khoruts, Kristin A. Hogquist, Christopher Staley, Daniel A. Winer, Xavier S. Revelo – 19 February 2021

Subscribe to